<?xml version="1.0" encoding="UTF-8"?>
<ref id="B149-viruses-12-00376">
 <label>149.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Galani</surname>
    <given-names>I.E.</given-names>
   </name>
   <name>
    <surname>Triantafyllia</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Eleminiadou</surname>
    <given-names>E.-E.</given-names>
   </name>
   <name>
    <surname>Koltsida</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Stavropoulos</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Manioudaki</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Thanos</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Doyle</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Kotenko</surname>
    <given-names>S.V.</given-names>
   </name>
   <name>
    <surname>Thanopoulou</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Interferon-Î» Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness</article-title>
  <source>Immunity</source>
  <year>2017</year>
  <volume>46</volume>
  <fpage>875</fpage>
  <lpage>890</lpage>
  <pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.025</pub-id>
  <pub-id pub-id-type="pmid">28514692</pub-id>
 </element-citation>
</ref>
